Security key
31189P102
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 285
- Total 13F value
- $770
- Share change
- 0
- SEC-reported price per share
- $2.70
- Number of holders
- 1
- Shares outstanding
- 122,342,805
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
FATE full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
FATE THERAPEUTICS INC SEC filings
FATE THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31189P102
Recent filing periods:
Ownership snapshot
Top reported holders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Redmile Group, LLC
Disclosed value leader
Redmile Group, LLC
Comparable rows
15/15
Latest evidence
12 Jun 2026
3/4/5
13D/G
13F
Lead comparable stake: 15%
13D/G row: Redmile Group, LLC
Showing 1-6 of 15 holder rows.
Quick read
Redmile Group, LLC leads the comparable SEC ownership view at 15%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Redmile Group, LLC's linked filing trail.
Comparable ownership
Top 5
Redmile Group, LLC
15%
BlackRock, Inc.
6.9%
GOLDMAN SACHS GROUP INC
2%
Schonfeld Strategic Advisors LLC
0.82%
VANGUARD CAPITAL MANAGEMENT LLC
3.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Redmile Group, LLC |
3/4/5
13D/G
13F
Director, 10%+ Owner · Company
|
15%
from 13D/G
|
$39,557,706
20,123,706 shares
mixed-class rows
|
— | 12 Jun 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
6.9%
from 13D/G
|
$12,082,337
10,068,614 shares
|
— | 31 Mar 2026 |
| GOLDMAN SACHS GROUP INC |
13D/G
13F
THE GOLDMAN SACHS GROUP, INC. · Company
|
2%
|
$2,546,902
2,274,020 shares
|
-$6,958,784 | 30 Jun 2025 |
| Schonfeld Strategic Advisors LLC |
13D/G
|
0.82%
|
$1,050,024
937,521 shares
|
-$7,679,831 | 30 Jun 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
3.4%
|
$5,030,476
4,192,063 shares
|
— | 31 Mar 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
Company
|
3.4%
|
$4,961,502
4,134,585 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
285
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
155
Q2 2026 holders
1
Holder diff
-154
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend